Adult-onset Langerhans cell histiocytosis presenting with adipsic diabetes insipidus, diabetes mellitus and hypopituitarism: A case report and review of literature

Erick S. Mendoza1, Amy A. Lopez1, Valerie Ann U. Valdez1, Jean D. Uy-Ho1, Sjoberg A. Kho1
1Section of Endocrinology Diabetes and Metabolism, Department of Medicine, University of Santo Tomas Hospital, Manila, Philippines

Tài liệu tham khảo

Badalian-Very, 2010, Recurrent BRAF mutations in Langerhans cell histiocytosis, Blood, 116, 1919, 10.1182/blood-2010-04-279083 Arico, 2003, Langerhans cell histiocytosis in adults. Report from the International Registry of the Histiocyte Society, Eur J Cancer, 39, 2341, 10.1016/S0959-8049(03)00672-5 Histiocyte Society: www.histiocytesociety.org; 2011. Kaltsas, 2000, Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological and radiological features and response to treatment, J Clin Endocrinol Metab, 85, 1370, 10.1210/jcem.85.4.6501 Grois, 2006, Risk factors for diabetes insipidus in langerhans cell histiocytosis, Pediatr Blood Cancer, 46, 228, 10.1002/pbc.20425 Grois, 1995, Diabetes insipidus in Langerhans cell histiocytosis: results from the DAL-HX 83 study, Med Pediatr oncol, 24, 248, 10.1002/mpo.2950240407 Shioda, 2011, Analysis of 43 cases of Langerhans cell istiocytosis (LCH)-induced cenral diabetes insipidus registered in JLSG-96 and JLSG-02 studies in Japan, Int J Hematol, 94, 545, 10.1007/s12185-011-0965-x Choi, 2014, Adult multisystem Langerhans cell histiocytosis presenting with central diabetes insipidus successfully treated with chemotherapy, Endocrinol Metab, 29, 394, 10.3803/EnM.2014.29.3.394 Crowley, 2007, Clinical insights into adipsic diabetes insipidus: a large case series, Clin Endocrinol (Oxf), 66, 475 Alexandraki, 2008, Cardiovascular risk factors in adult patients with multisystem Langerhans-cell histiocytosis: evidence of glucose metabolism abnormalities, QJM, 101, 31, 10.1093/qjmed/hcm118 Goyal, 2007, Langerhans cell histiocytosis infiltration into pancreas and kidney, Pediatr Blood Cancer, 49, 748, 10.1002/pbc.20746 Minkov, 2011, Multisystem Langerhans cell histiocytosis in children: current treatment and future directions, Paediatr Drugs, 13, 75, 10.2165/11538540-000000000-00000 Gadner, 2001, A randomized trial of treatment for multisystem langerhans' cell histiocytosis, J Pediatr, 138, 728, 10.1067/mpd.2001.111331 Schini, 2013, Cladribine therapy in adults with advanced langerhans cell histiocytosis, Leuk Lymphoma, 54, 1541, 10.3109/10428194.2012.744454 Cantu, 2012, Optimal therapy for adults with langerhans cell histiocytosis bone lesions, PLoS One, 7, e43257, 10.1371/journal.pone.0043257 Haroche, 2013, Dramatic efficacy of vemurafenib in both multisystemic and refractory Ederheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation, Blood, 121, 1459, 10.1182/blood-2012-07-446286